Skip to content
bioarctic-gunilla-oswald-people-2

Gunilla Osswald

CEO

Born: 1961

Employed since: 2013

Other assignments: Board member of Egetis Therapeutics AB and SpineMedical AB.

Education: Pharmacist; Ph.D. in biopharmacy and pharmacokinetics at Uppsala University, Sweden.

Experience and prior assignments: More than 30 years of experience in drug development. Executive positions at Astra/ AstraZeneca, including Vice President responsible for the product portfolio in neurodegenerative diseases. Board member of SP Process Development AB.

Member of BioArctic’s senior management since: 2013

Total holdings* and warrants in BioArctic75,070 Class B shares.
Warrants granting acquisition rights to 150,000 Class B shares (2019/2028 program).

bioarctic-Gunilla-Andersson-people

Gunilla Andersson

Vice President HR

Born: 1961

Employed since: 2019 (contracted since 2014)

Other assignments: Manages her own consulting company focusing on HR.

Education: B.Sc. Human Resource Development and Labor Relations with a specialization in labor rights from Lund University, Sweden.

Experience and prior assignments: 30 years of experience as HR consultant and HR manager in educational organizations and pharma companies such as Pharmacia and Novartis.

Member of BioArctic’s senior management since: 2019

Total holdings* and warrants in BioArctic: 0 shares.
Warrants granting acquisition rights to 20,000 Class B shares (2019/2028 program)

bioarctic-oskar-bosson-people-2

Oskar Bosson

Vice President Investor Relations & Communications

Born1976

Employed since: 2020

Other assignments

EducationM.Sc. Molecular Biotechnology and B.A. in Business Administration from Uppsala University

Experience and prior assignments: 17 years of experience from the communication field globally. Held senior positions in companies such as Sobi, Ovako and most recently Elekta.

Member of BioArctic’s senior management since: 2020

Total holdings* and warrants in BioArctic: 3,793 Class B shares.
Warrants granting acquisition rights to 20,000 Class B shares (2019/2028 program)

bioarctic-johanna-falting-people-2

Johanna Fälting

Vice President Head of Research

Born: 1972

Employed since: 2012

Other assignments: –

Education: Ph.D. in Physiology, Stockholm University; Licentiate degree in physiology, Stockholm University; Master’s degree in biology, Stock-holm University, Sweden.

Experience and prior assignments: 19 years of experience in neuroscience/ pharmacology, drug research, translational science and development in the global pharma and biotech industry.

Member of BioArctic’s senior management since: 2012

Total holdings* and warrants in BioArctic: 38,355 Class B shares.
Warrants granting acquisition rights to 20,000 Class B shares (2019/2028 program)

bioarctic-anna-kaija-people-3

Anna-Kaija Grönblad

Chief Commercial Officer

Born: 1968

Employed since: 2021 (contracted since 2020)

Other assignments: –

Education: B.A. in Business Administration from Uppsala University, Sweden.

Experience and prior assignments: 25 years of experience from the pharmaceutical industry and private healthcare. Over the years, she has worked in various commercial roles in Sweden and the Nordic and Baltic countries, and in a number of therapy areas with a focus on market access, launch preparations and organizational development. She most recently came from the role as CEO of Sanofi AB, where she was also General Manager Nordic & Baltic countries for General Medicine.

Member of BioArctic’s senior management since: 2021

Total holdings* and warrants in BioArctic: 9,300 Class B shares, privately and through Saimi AB. Warrants granting acquisition rights to 20,000 Class B shares (2019/2028 program)

bioarctic-Lars-Lannfelt-people

Lars Lannfelt

Senior Vice President University Collaborations. Founder of BioArctic in 2003.

Born: 1949

Employed since: 2016

Other assignments: Board member of Demban AB and LPB Sweden AB.

Education: Medical degree (specialist in psychiatry) and doctoral thesis at Karolinska Institutet, Stockholm, Sweden; Associate Professor of Neurogenetics at Karolinska Institutet, specialist in geriatrics.

Experience and prior assignments: More than 35 years of experience in research into Alzheimer’s disease and other neurodegenerative diseases. Professor of Geriatrics at Uppsala University; Senior Professor at Uppsala University and member of the Royal Swedish Academy of Sciences. Founder of BioArctic in 2003, Chairman of the Board and a number of assignments and roles in the company.

Member of BioArctic’s senior management since: 2003

Total holdings* and warrants in BioArctic:
8,639,998 Class A shares through Demban AB.
20,885,052 Class B shares through Demban AB.
0 warrants

bioarctic-Jan-Mattsson-people

Jan Mattsson

Vice President Finance, CFO

Born: 1960

Employed at the company since: 2017.

Other assignments – Experience and prior assignments: More than 30 years of experience in business and administration, including CFO at Sefina Finance AB, Allenex AB, Argnor Wireless Ventures AB, Logitall AB and Investment AB Kinnevik.

Education: MBA from Örebro University.

Member of BioArctic’s senior management since: 2017

Total holdings* and warrants in BioArctic: 36,270 Class B shares, privately and through Almsäter Interim Management AB.
Warrants granting acquisition rights to 20,000 Class B shares (2019/2028 program

bioarctic-mikael-moge-people

Mikael Moge

Vice President Chemistry, Manufacturing & Control

Born: 1967

Employed since: 2012

Other assignments – Experience and prior assignments: 23 years of experience in drug development and 19 years of experience as R&D director in process development and GMP manufacturing. Former section manager in Process R&D at AstraZeneca.

Education: Master of Engineering chemical engineering, KTH Royal Institute of Technology; Ph.D. in organic chemistry, KTH; Stockholm, Sweden.

Member of BioArctic’s senior management since: 2012

Total holdings* and warrants in BioArctic: 9,360 Class B shares.
Warrants granting acquisition rights to 19,000 Class B shares (2019/2028 program)

bioarctic-christer-moller-people-2

Christer Möller

Vice President Pre-Clinical Development, Chief Scientific Officer

Born: 1959

Employed at the company since: 2006.

Other assignments – Experience and prior assignments: 21 years of experience in developing protein drugs from idea to clinical trials including leading positions at small biotech/pharma companies such as Zymenex A/S. In addition, comprehensive academic experience in pursuing research projects concerning growth factors and preclinical research in diabetes.

Education: B.Sc. in Biology, Stockholm University, Sweden; Ph.D. in Medical Science, Karolinska Institutet, Stockholm, Sweden.

Member of BioArctic’s senior management since: 2006

Total holdings* and warrants in BioArctic: 52,770 Class B shares.
Warrants granting acquisition rights to 21,000 Class B shares (2019/2028 program)

bioarctic-tomas-odengren-people-2

Tomas Odergren

Chief Medical Officer

Born: 1959

Employed since: 2019 (contracted since 2016)

Other assignment: Senior Clinical Consultant at GKeller Consulting

Education: MD Uppsala University, PhD Karolinska Institute, Neurologist certified by the Swedish Medical Society, Diploma in Pharmaceutical Medicine EUCOR/ECPM.

Experience and prior assignments: More than 20 years’ experience from the pharmaceutical industry in leading positions in clinical development at AstraZeneca and H Lundbeck. Chief Specialist ICR Neurology H Lundbeck A/S (2015-2017)

Member of BioArctic’s senior management since: 2020

Total holdings* and warrants in BioArctic: 5,700 Class B-shares.
Warrants granting acquisition rights to 20,000 Class B shares (2019/2028 program)

*Includes holdings by self, closely associated persons, controlled companies or otherwise controlled.

Loading...